Clinical Trial

The EMBRACE Registry: European Post-Market Registry for Catheter Based Mitral Valve Replacement

Study acronym: EMBRACE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Post-market registry for post-market surveillance, as part of the post-market plan, for the HighLife transcatheter, transseptal, mitral valve replacement system in a real world commercial setting.
Trial Details
NCT Number NCT07409285
Lead Sponsor HighLife SAS
Conditions Mitral Regurgitation
Enrollment 150 participants
Start Date 2026-03-14
Primary Completion 2029-04-15 (estimated)
Study Completion 2031-04-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-13